These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3765639)
1. [Current concepts in the pathogenesis of celiac disease]. Auricchio S Wien Klin Wochenschr; 1986 Aug; 98(16):517-20. PubMed ID: 3765639 [TBL] [Abstract][Full Text] [Related]
4. Celiac disease: from pathogenesis to novel therapies. Schuppan D; Junker Y; Barisani D Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641 [TBL] [Abstract][Full Text] [Related]
5. The use of extended amino acid motifs for focussing on toxic peptides in coeliac disease. McLachlan A; Cullis PG; Cornell HJ J Biochem Mol Biol Biophys; 2002 Oct; 6(5):319-24. PubMed ID: 12385967 [TBL] [Abstract][Full Text] [Related]
6. Is gliadin harmful from the first morsel? Dieterich W; Schuppan D Dig Liver Dis; 2007 Oct; 39(10):917-21. PubMed ID: 17720638 [No Abstract] [Full Text] [Related]
7. Gluten-sensitive enteropathy. Luchetti R; De Vincenzi M Ann Ist Super Sanita; 1995; 31(3):323-36. PubMed ID: 8712576 [TBL] [Abstract][Full Text] [Related]
8. Direct gliadin cytotoxicity as a cofactor in the pathogenesis of celiac disease. Elli L; Dolfini E; Bardella MT Int Arch Allergy Immunol; 2004 May; 134(1):88. PubMed ID: 15133305 [No Abstract] [Full Text] [Related]
11. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Verdu EF; Huang X; Natividad J; Lu J; Blennerhassett PA; David CS; McKay DM; Murray JA Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G217-25. PubMed ID: 18006603 [TBL] [Abstract][Full Text] [Related]
12. Adaptive and innate immune responses in celiac disease. Gianfrani C; Auricchio S; Troncone R Immunol Lett; 2005 Jul; 99(2):141-5. PubMed ID: 15876458 [TBL] [Abstract][Full Text] [Related]
13. Studies on the aetiology of coeliac disease: no evidence for lectin-like components in wheat gluten. Rühlmann J; Sinha P; Hansen G; Tauber R; Köttgen E Biochim Biophys Acta; 1993 Jun; 1181(3):249-56. PubMed ID: 8318550 [TBL] [Abstract][Full Text] [Related]
14. Structural specificities and significance for coeliac disease of wheat gliadin peptides able to agglutinate or to prevent agglutination of K562(S) cells. De Vincenzi M; Stammati A; Luchetti R; Silano M; Gasbarrini G; Silano V Toxicology; 1998 May; 127(1-3):97-106. PubMed ID: 9699797 [TBL] [Abstract][Full Text] [Related]
15. [Recent aspects of antibody determination for the diagnosis of coeliac disease]. Mothes T; Uhlig HH; Richter T Dtsch Med Wochenschr; 2009 Jul; 134(30):1525-8. PubMed ID: 19603369 [TBL] [Abstract][Full Text] [Related]
16. Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis. Heyman M; Abed J; Lebreton C; Cerf-Bensussan N Gut; 2012 Sep; 61(9):1355-64. PubMed ID: 21890812 [TBL] [Abstract][Full Text] [Related]
17. Serum antibodies to gliadin and other cereal proteins in patients with coeliac disease and dermatitis herpetiformis. Kieffer M Dan Med Bull; 1985 Oct; 32(5):251-62. PubMed ID: 4053695 [No Abstract] [Full Text] [Related]